HOB Selling General Administrative vs Total Revenue Analysis

688656 Stock

95.13 1.87 2.01%

HOB Biotech financial indicator trend analysis is much more than just examining HOB Biotech Group latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether HOB Biotech Group is a good investment. Please check the relationship between HOB Biotech Selling General Administrative and its Total Revenue accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in HOB Biotech Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Selling General Administrative vs Total Revenue

Selling General Administrative vs Total Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of HOB Biotech Group Selling General Administrative account and Total Revenue. At this time, the significance of the direction appears to have strong relationship.

The correlation between HOB Biotech's Selling General Administrative and Total Revenue is 0.61. Overlapping area represents the amount of variation of Selling General Administrative that can explain the historical movement of Total Revenue in the same time period over historical financial statements of HOB Biotech Group, assuming nothing else is changed. The correlation between historical values of HOB Biotech's Selling General Administrative and Total Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Selling General Administrative of HOB Biotech Group are associated (or correlated) with its Total Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Revenue has no effect on the direction of Selling General Administrative i.e., HOB Biotech's Selling General Administrative and Total Revenue go up and down completely randomly.

Correlation Coefficient

0.61

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Selling General Administrative

Total Revenue

Total revenue comprises all receipts HOB Biotech Group generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Most indicators from HOB Biotech's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into HOB Biotech Group current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in HOB Biotech Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

The current year's Selling General Administrative is expected to grow to about 49.5 M, whereas Tax Provision is forecasted to decline to about 7.2 M.

	2022	2024	2025 (projected)
Interest Expense	1.9M	2.9M	1.9M
Depreciation And Amortization	33.3M	38.2M	40.2M

Interest Expense Depreciation And Amortization

HOB Biotech fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Long Term Debt	Net Receivables	Net Invested Capital
Total Assets		0.66	-0.1	0.83	1.0	0.97	-0.63	0.98	0.75	0.74	0.97	-0.05	0.95	0.94	-0.68	0.88	-0.64	1.0	0.82	0.87	0.64	0.81	0.83	0.85	0.93	0.96
Short Long Term Debt Total	0.66		-0.24	0.82	0.64	0.73	-0.07	0.68	0.79	0.24	0.73	0.06	0.49	0.76	-0.45	0.81	-0.71	0.63	0.82	0.48	0.95	0.71	0.55	0.67	0.71	0.72
Other Current Liab	-0.1	-0.24		0.16	-0.12	-0.28	-0.34	-0.22	-0.02	0.26	-0.29	-0.49	0.04	-0.12	0.34	-0.03	0.14	-0.12	0.21	0.24	-0.2	0.26	0.26	-0.03	-0.21	-0.13
Total Current Liabilities	0.83	0.82	0.16		0.81	0.82	-0.41	0.77	0.82	0.54	0.82	-0.16	0.74	0.86	-0.58	0.92	-0.57	0.81	0.99	0.75	0.85	0.84	0.82	0.71	0.77	0.83
Total Stockholder Equity	1.0	0.64	-0.12	0.81		0.96	-0.65	0.99	0.74	0.76	0.96	-0.03	0.96	0.94	-0.69	0.87	-0.64	1.0	0.8	0.88	0.63	0.8	0.82	0.85	0.93	0.96
Property Plant And Equipment Net	0.97	0.73	-0.28	0.82	0.96		-0.42	0.97	0.75	0.55	1.0	-0.02	0.85	0.9	-0.71	0.87	-0.62	0.95	0.81	0.72	0.7	0.72	0.75	0.78	0.9	0.91
Net Debt	-0.63	-0.07	-0.34	-0.41	-0.65	-0.42		-0.58	-0.29	-0.98	-0.42	0.06	-0.84	-0.61	0.38	-0.48	0.37	-0.66	-0.38	-0.88	-0.11	-0.62	-0.64	-0.62	-0.61	-0.65
Retained Earnings	0.98	0.68	-0.22	0.77	0.99	0.97	-0.58		0.71	0.69	0.97	-0.06	0.92	0.92	-0.64	0.87	-0.7	0.98	0.77	0.82	0.62	0.8	0.79	0.88	0.95	0.94
Accounts Payable	0.75	0.79	-0.02	0.82	0.74	0.75	-0.29	0.71		0.41	0.74	0.19	0.64	0.79	-0.38	0.74	-0.5	0.75	0.82	0.67	0.78	0.65	0.61	0.72	0.67	0.81
Cash	0.74	0.24	0.26	0.54	0.76	0.55	-0.98	0.69	0.41		0.55	-0.05	0.91	0.74	-0.47	0.62	-0.48	0.77	0.52	0.94	0.27	0.72	0.73	0.72	0.73	0.77
Non Current Assets Total	0.97	0.73	-0.29	0.82	0.96	1.0	-0.42	0.97	0.74	0.55		-0.01	0.85	0.9	-0.72	0.87	-0.63	0.96	0.81	0.72	0.71	0.72	0.74	0.78	0.9	0.91
Non Currrent Assets Other	-0.05	0.06	-0.49	-0.16	-0.03	-0.02	0.06	-0.06	0.19	-0.05	-0.01		-0.02	0.06	-0.32	-0.24	-0.02	0.02	-0.23	-0.08	0.21	-0.35	-0.46	-0.19	-0.09	0.08
Cash And Short Term Investments	0.95	0.49	0.04	0.74	0.96	0.85	-0.84	0.92	0.64	0.91	0.85	-0.02		0.91	-0.65	0.8	-0.6	0.96	0.72	0.96	0.51	0.8	0.82	0.83	0.89	0.93
Common Stock Shares Outstanding	0.94	0.76	-0.12	0.86	0.94	0.9	-0.61	0.92	0.79	0.74	0.9	0.06	0.91		-0.67	0.93	-0.62	0.94	0.83	0.88	0.76	0.81	0.81	0.87	0.95	0.99
Non Current Liabilities Total	-0.68	-0.45	0.34	-0.58	-0.69	-0.71	0.38	-0.64	-0.38	-0.47	-0.72	-0.32	-0.65	-0.67		-0.55	0.32	-0.7	-0.5	-0.49	-0.62	-0.33	-0.42	-0.28	-0.58	-0.67
Inventory	0.88	0.81	-0.03	0.92	0.87	0.87	-0.48	0.87	0.74	0.62	0.87	-0.24	0.8	0.93	-0.55		-0.6	0.86	0.91	0.79	0.76	0.87	0.89	0.87	0.93	0.91
Other Current Assets	-0.64	-0.71	0.14	-0.57	-0.64	-0.62	0.37	-0.7	-0.5	-0.48	-0.63	-0.02	-0.6	-0.62	0.32	-0.6		-0.63	-0.58	-0.56	-0.61	-0.79	-0.43	-0.69	-0.68	-0.61
Other Stockholder Equity	1.0	0.63	-0.12	0.81	1.0	0.95	-0.66	0.98	0.75	0.77	0.96	0.02	0.96	0.94	-0.7	0.86	-0.63		0.79	0.88	0.63	0.78	0.8	0.84	0.92	0.96
Total Liab	0.82	0.82	0.21	0.99	0.8	0.81	-0.38	0.77	0.82	0.52	0.81	-0.23	0.72	0.83	-0.5	0.91	-0.58	0.79		0.74	0.81	0.86	0.83	0.73	0.75	0.81
Total Current Assets	0.87	0.48	0.24	0.75	0.88	0.72	-0.88	0.82	0.67	0.94	0.72	-0.08	0.96	0.88	-0.49	0.79	-0.56	0.88	0.74		0.49	0.85	0.85	0.85	0.84	0.9
Short Term Debt	0.64	0.95	-0.2	0.85	0.63	0.7	-0.11	0.62	0.78	0.27	0.71	0.21	0.51	0.76	-0.62	0.76	-0.61	0.63	0.81	0.49		0.63	0.52	0.53	0.64	0.72
Intangible Assets	0.81	0.71	0.26	0.84	0.8	0.72	-0.62	0.8	0.65	0.72	0.72	-0.35	0.8	0.81	-0.33	0.87	-0.79	0.78	0.86	0.85	0.63		0.86	0.88	0.83	0.79
Common Stock	0.83	0.55	0.26	0.82	0.82	0.75	-0.64	0.79	0.61	0.73	0.74	-0.46	0.82	0.81	-0.42	0.89	-0.43	0.8	0.83	0.85	0.52	0.86		0.82	0.81	0.8
Long Term Debt	0.85	0.67	-0.03	0.71	0.85	0.78	-0.62	0.88	0.72	0.72	0.78	-0.19	0.83	0.87	-0.28	0.87	-0.69	0.84	0.73	0.85	0.53	0.88	0.82		0.93	0.88
Net Receivables	0.93	0.71	-0.21	0.77	0.93	0.9	-0.61	0.95	0.67	0.73	0.9	-0.09	0.89	0.95	-0.58	0.93	-0.68	0.92	0.75	0.84	0.64	0.83	0.81	0.93		0.95
Net Invested Capital	0.96	0.72	-0.13	0.83	0.96	0.91	-0.65	0.94	0.81	0.77	0.91	0.08	0.93	0.99	-0.67	0.91	-0.61	0.96	0.81	0.9	0.72	0.79	0.8	0.88	0.95

Click cells to compare fundamentals

HOB Biotech Account Relationship Matchups

HOB Biotech fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	296.4M	863.9M	944.6M	949.3M	1.1B	1.1B
Short Long Term Debt Total	50.1M	44.0M	30.9M	65.4M	75.2M	44.6M
Other Current Liab	35.7M	49.5M	48.7M	3.1M	3.6M	3.4M
Total Current Liabilities	63.2M	86.2M	152.7M	135.8M	156.1M	102.6M
Total Stockholder Equity	206.4M	770.0M	779.6M	810.7M	932.3M	979.0M
Property Plant And Equipment Net	120.0M	260.0M	485.3M	578.7M	665.5M	698.8M
Net Debt	(40.7M)	(14.8M)	(419.0M)	(88.4M)	(79.5M)	(83.5M)
Retained Earnings	72.9M	131.3M	133.9M	162.1M	186.4M	195.8M
Accounts Payable	7.5M	11.1M	48.3M	23.9M	27.5M	15.2M
Cash	58.8M	449.9M	153.8M	163.5M	188.0M	138.9M
Non Current Assets Total	137.8M	293.9M	521.6M	621.0M	714.2M	749.9M
Non Currrent Assets Other	5.5M	20.1M	21.9M	16.4M	18.9M	16.5M
Cash And Short Term Investments	90.8M	58.8M	454.9M	289.0M	332.4M	349.0M
Common Stock Shares Outstanding	47.2M	61.6M	63.1M	63.1M	72.5M	57.6M
Liabilities And Stockholders Equity	283.2M	296.4M	863.9M	944.6M	1.1B	1.1B
Non Current Liabilities Total	26.8M	7.8M	12.3M	2.8M	2.5M	2.4M
Inventory	61.9M	68.2M	87.8M	111.2M	127.9M	69.7M
Other Current Assets	1.3M	3.0M	3.9M	959.4K	863.5K	820.3K
Other Stockholder Equity	79.3M	86.1M	575.6M	582.6M	670.0M	703.5M
Total Liab	90.0M	93.9M	165.0M	138.5M	159.3M	116.4M
Total Current Assets	158.7M	570.0M	423.0M	328.2M	377.4M	263.7M
Short Term Debt	45.0M	20.0M	25.5M	55.7M	64.0M	34.4M
Intangible Assets	11.3M	12.2M	12.6M	11.9M	13.6M	8.4M
Net Receivables	29.9M	37.5M	32.4M	41.5M	47.7M	35.5M
Net Invested Capital	250.4M	795.5M	835.3M	860.8M	989.9M	647.2M
Short Long Term Debt	20.0M	25.5M	55.7M	50.0M	57.5M	43.2M
Net Working Capital	95.4M	483.8M	270.3M	192.5M	221.3M	241.0M

Currently Active Assets on Macroaxis

V	Visa Class A
CRM	Salesforce
CRM	Salesforce
MSFT	Microsoft
V	Visa Class A

Other Information on Investing in HOB Stock

Balance Sheet is a snapshot of the financial position of HOB Biotech Group at a specified time, usually calculated after every quarter, six months, or one year. HOB Biotech Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of HOB Biotech and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which HOB currently owns. An asset can also be divided into two categories, current and non-current.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

HOB Selling General Administrative vs Total Revenue Analysis

Selling General Administrative vs Total Revenue

Selling General Administrative vs Total Revenue Correlation Analysis

Correlation Coefficient

Selling General Administrative

Total Revenue

HOB Biotech fundamental ratios Correlations

HOB Biotech Account Relationship Matchups

High Positive Relationship

High Negative Relationship

HOB Biotech fundamental ratios Accounts

Currently Active Assets on Macroaxis

Other Information on Investing in HOB Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Other Stockholder Equity	+ 1.0	Total Assets
Other Stockholder Equity	+ 1.0	Total Stockholder Equity
Non Current Assets Total	+ 1.0	Property Plant And Equipment Net
Total Liab	+ 0.99	Total Current Liabilities
Retained Earnings	+ 0.99	Total Stockholder Equity

Cash	- 0.98	Net Debt
Total Current Assets	- 0.88	Net Debt
Cash And Short Term Investments	- 0.84	Net Debt
Intangible Assets	- 0.79	Other Current Assets
Non Current Liabilities Total	- 0.72	Non Current Assets Total
Non Current Liabilities Total	- 0.71	Property Plant And Equipment Net